Clinical Trial Update: Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of N-acetylcysteine in preventing or mitigating liver toxicity caused by anti-tuberculosis drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Viral Hepatitis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: National Research Institute of Tuberculosis and Lung Disease, Iran | Conditions: Hepatitis, Tuberculosis | NA | Status: COMPLETED